![Erik Chi-Lik Ng](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Erik Chi-Lik Ng
Chief Executive Officer at
Xing Ling International Pte Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Julian Sandt | M | - |
Xing Ling International Pte Ltd.
 Xing Ling International Pte Ltd. Medical DistributorsDistribution Services Distributes Chinese and Western medicine | - |
| Phillip Khoo | M | - |
Xing Ling International Pte Ltd.
Xing Ling International Pte Ltd. Medical DistributorsDistribution Services Distributes Chinese and Western medicine | - |
See more
Connections Chart
Multi-company connection
Past Relations
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert E. Pelzer | M | 72 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | 6 years |
| Malcolm W. MacNab | M | 79 |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | 7 years |
| James Caruso | M | 66 |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | 1 years |
| Rachel King | F | 66 |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | 2 years |
| John Kelly | M | 59 |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | 1 years |
| A. Schobel | M | 70 |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | 4 years |
| David Parkinson | M | 75 |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | 6 years |
| Reinhard Ambros | M | 70 |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | 4 years |
| Arun Nadiga | M | - |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | 7 years |
| Patrick Gan | M | 68 |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | 1 years |
| Chadwick J. Orevillo | M | - |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | 5 years |
| Yves Teirlynck | M | - |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | - |
| Sandra Silberman | M | 71 |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | 4 years |
| John D. Menditto | M | - |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | 7 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 14 | 87.5% |
| Singapore | 2 | 12.5% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Provenance des relations
- Stock Market
- Insiders
- Erik Chi-Lik Ng
- Personal Network
